马拉维儿童严重营养不良后青少年期长期结局:LOCSM前瞻性观察队列研究
本研究随访15年前在马拉维接受治疗的168名严重营养不良青少年,并比较123名兄弟姐妹和89名社区青少年。结果显示,营养不良组身高年龄Z评分仍较低,但青春期有 modest 追赶生长;除内化症状评分略高外,其他代谢和认知指标无显著差异。
要点
- 严重营养不良青少年青春期身高Z评分仍低于兄弟姐妹和社区同龄人。
- 未发现非传染性疾病风险显著升高,但需长期监测。
- 内化行为症状评分在营养不良组略高,差异接近零。
核心结论
- 严重儿童营养不良后青少年期身高缺陷持续存在,但青春期有 modest 追赶生长。
- 未发现非传染性疾病风险显著升高,长期健康影响需监测。
研究设计与样本
- 前瞻性观察队列研究,随访15年前在马拉维伊丽莎白中央医院接受治疗的严重营养不良青少年。
- 比较168名营养不良青少年、123名兄弟姐妹和89名社区青少年,调整年龄、性别、残疾、HIV和社会经济状态。
主要发现
- 其他测量变量未发现营养不良组与未暴露组间差异。
临床怎么用
- 对严重营养不良康复儿童应持续监测身高和行为症状至青春期。
- 目前证据不支持常规筛查非传染性疾病风险,但需个体化长期随访。
局限性
- 观察性设计不能完全排除混杂因素。
- 样本来自单一中心,外推性有限。
- 部分比较置信区间包含零,需谨慎解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research on long-term outcomes of severe childhood malnutrition is scarce. Existing evidence suggests potential associations with cardiometabolic disease and impaired cognition. We aimed to assess outcomes in adolescents who were exposed to severe childhood malnutrition compared with peers not exposed to severe childhood malnutrition. METHODS: In Long-term Outcomes after Severe Childhood Malnutrition (LOCSM), we followed up adolescents who had 15 years earlier received treatment for severe childhood malnutrition at Queen Elizabeth Central Hospital in Blantyre, Malawi. Adolescents with previous severe childhood malnutrition included in LOCSM had participated in an earlier follow-up study (ChroSAM) at 7 years after treatment for severe childhood malnutrition, where they were compared to siblings and age-matched children in the community without previous severe childhood malnutrition. We measured anthropometry, body composition, strength, glucose tolerance, cognition, behaviour, and mental health during follow-up visits between Sept 9, 2021, and July 22, 2022, comparing outcomes in adolescents exposed to previous severe childhood malnutrition with unexposed siblings and adolescents from the community assessed previously (for ChroSAM) and newly recruited during current follow-up. We used a linear regression model to adjust for age, sex, disability, HIV, and socioeconomic status. This study is registered with the International Standard Randomised Controlled Trial Number Registry (ISRCTN17238083). FINDINGS: We followed up 168 previously malnourished adolescents (median age 17·1 years [IQR 16·5 to 18·0]), alongside 123 siblings (18·2 years [15·0 to 20·5]), and 89 community adolescents (17·1 years [16·3 to 18·1]). Since last measured 8 years previously, mean height-for-age Z (HAZ) scores had improved in previously malnourished adolescents (difference 0·33 [95% CI 0·20 to 0·46]) and siblings (0·32 [0·09 to 0·55]), but not in community adolescents (difference -0·01 [-0·24 to 0·23]). Previously malnourished adolescents had sustained lower HAZ scores compared with siblings (adjusted difference -0·32 [-0·58 to -0·05]) and community adolescents (-0·21 [-0·52 to 0·10]). The adjusted difference in hand-grip strength between previously malnourished adolescents and community adolescents was -2·0 kg (-4·2 to 0·3). For child behaviour checklist internalising symptom scores, the adjusted difference for previously malnourished adolescents was 2·8 (0·0 to 5·5) compared with siblings and 2·1 (-0·1 to 4·3) compared with community adolescents. No evidence of differences between previously malnourished adolescents and unexposed groups were found in any of the other variables measured. INTERPRETATION: Catch-up growth into adolescence was modest compared with the rapid improvement seen in childhood, but provides optimism for ongoing recovery of height deficits. We found little evidence of heightened non-communicable disease risk in adolescents exposed to severe childhood malnutrition, although long-term health implications need to be monitored. Further investigation of associated home and environmental factors influencing long-term outcomes is needed to tailor preventive and treatment interventions. FUNDING: The Wellcome Trust.
引用
- Kirolos A, Harawa PP, Chimowa T, et al. Long-term outcomes after severe childhood malnutrition in adolescents in Malawi (LOSCM): a prospective observational cohort study. Lancet Child Adolesc Health. 2024. PMID: 38368896. doi:10.1016/S2352-4642(23)00339-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。